Chemotherapy of solid tumors

References

• Nissen-Meyer R, Kjellgren K, Manson B: Preliminary report from the Scandinavian adjuvant chemotherapy study group. Cancer Chemother Rep 55:561–566, 1971
   PubMedGoogle Scholar
• Fisher B: Surgical adjuvant therapy for breast cancer. Cancer 30:1556–1664, 1972
   PubMed Web of Science ®Google Scholar
• Donegan WL: Extended surgical adjuvant thiotepa for mammary carcinoma. Arch Surg 109:187–192, 1974
   PubMedGoogle Scholar
• Fisher B, Carbone P, Economou SG, et al: L-PAM in the management of primary breast cancer. N Engl J Med 292:117–123, 1975
   PubMed Web of Science ®Google Scholar
• Schabel F: Animal models as predictive systems. In Cancer Chemotherapy: Fundamental Concepts & Recent Advances. Chicago, Year Book Medical Publishers, Inc, 1975, pp 323–355
   Google Scholar
• Bonadonna G: Data presented at Breast Cancer Task Force Conference, National Cancer Institute, Bethesda, MD, March 1975
   Google Scholar
• Livingston R, Carter S: Single Agents in Cancer Chemotherapy. New York, Plenum Medical Book Co, 1970
   Google Scholar
• Hoogstraten B, George S: Adriamycin and combination chemotherapy in breast cancer: A Southwest Oncology Group study. Proc AACR 15:279, 1974
   Google Scholar
• Bull J, Tormey D, Falkson G: A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil versus cyclophosphamide, methotrexate and 5-fluorouracil in metastatic breast cancer. Proc ASCO 16:246, 1975
   Google Scholar
• De Lena M, Brambilla C, Morabito A: Adriamycin + vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer. Cancer 35:1108–1115, 1975
   PubMed Web of Science ®Google Scholar
• Canellos GP, Devita VJ, Gold GL, et al: Cyclical combination chemotherapy for advanced breast carcinoma. Br Med J 1:218–220, 1974
   PubMedGoogle Scholar
• Creech R, Catalano R, Mastrangelo M: An effective low- dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer. Cancer 35:1101–1107, 1975
   PubMed Web of Science ®Google Scholar
• Cardenas J, Gutterman J, Blumenschein G: Chemoimmunotherapy of disseminated breast cancer: Prolongation of remission and survival with BCG. (Manuscript in preparation)
   Google Scholar
• Jones S, Durie B, Salmon SE: Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer. Cancer 36:90–97, 1975
   PubMed Web of Science ®Google Scholar
• Moore FD, VanDevanter SB, Boyden CM, et al: Adrenalectomy with chemotherapy in the treatment of advanced breast cancer: Objective and subjective response rates; duration and quality of life. Surgery 76:376–390, 1974
   PubMed Web of Science ®Google Scholar
• van Dyk J, Falkson G: Extended survival and remission rates in metastatic breast cancer. Cancer 27:300–303, 1971
   PubMed Web of Science ®Google Scholar
• McGuire WL, Carbone PP, Sears M: Estrogen receptors in human breast cancer: An overview. In McGuire WL, Carbone PP, Vollmer EP (Editors): Estrogen Receptors in Human Breast Cancer. New York, Raven Press, 1975, pp 1–7
   Google Scholar
• Heyn RM: The role of chemotherapy in the management of soft tissue sarcomas. Cancer 35:921–924, 1975
   PubMed Web of Science ®Google Scholar
• Blum R: Data presented at NCI new drug symposium on adriamycin (summary of American studies). Washington, DC, 1975
   Google Scholar
• Gottlieb JA, Baker LH, Burgess MA: Sarcoma chemotherapy. In Cancer Chemotherapy, 5 pp 445–455
   Google Scholar
• Jaffe N, Paed D, Farber S, et al: Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy. Cancer 31:1367–1373, 1973
   PubMed Web of Science ®Google Scholar
• Rosen G, Suwansirkul S, Kwon C, et al: High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer 33:1151–1163, 1974
   PubMed Web of Science ®Google Scholar
• Rosen G, Tan C, Sanmaneechai A, et al: The rationale for multiple-drug chemotherapy in the treatment of osteogenic sarcoma. Cancer 35:936–945, 1975
   PubMed Web of Science ®Google Scholar
• Frei E III, Jaffe N, Tattersall MH, et al: New approaches to cancer chemotherapy with methotrexate. N Engl J Med 292:846–851, 1975
   PubMed Web of Science ®Google Scholar
• Marcove RC, Mike V, Hajek JV, et al: Osteogenic sarcoma in childhood. NY State J Med 71:855–859, 15 Apr 1971
   PubMedGoogle Scholar
• Sutow W, Gehan E, Vietti TJ: Further experience with multidrug chemotherapy in primary treatment of osteogenic carcoma. Proc ASCO 16:232, 1975
   Google Scholar
• Cortes EP, Holland JF, Wang JJ: Adriamycin in primary osteosarcoma. Proc ASCO 16:241, 1975
   Google Scholar
• Gottlieb JA: Personal communication, 1975
   Google Scholar
• Jaffe N, Frei E III, Traggis D, et al: Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med 291:994–997, 1974
   PubMed Web of Science ®Google Scholar
• Rosen G, Marcove R, Beattie EJ: Osteogenic sarcoma: Sequential chemotherapy in 45 consecutive patients. Proc ASCO 16:227, 1975.
   Google Scholar
• Pitman S, Tattersall M, Frei E III: A phase I-II study of high-dose methotrexate with citrovorum-factor rescue. Proc ASCO 16:263, 1975
   Google Scholar
• Selawry O, Hansen H: Improved chemotherapy for advanced bronchogenic carcinoma. Proc AACR-ASCO 15:118, 1974
   Google Scholar
• Einhorn L, Farber M, Fee W: Bleomycin, adriamycin, Cytoxan and Oncovin combination chemotherapy in oat cell lung cancer. JAMA (in press)
   Google Scholar
• Holoye P, Hussey D, Samuels M: Combination intensive chemotherapy and radiotherapy in oat cell bronchogenic carcinoma. Proc AACR-ASCO 15:43, 1974
   Google Scholar
• Holoye P, Samuels M, Hussey D: Cytoxan, adriamycin and vincristine combination with radiation therapy in the treatment of small cell carcinoma of the lung. Proc AACR-ASCO 16:112, 1975
   Google Scholar
• Holoye PY: Chemotherapy of bronchogenic small cell carcinoma. In Cancer Chemotherapy,5 pp 215–232
   Google Scholar
• Samuels ML, et al: Combination chemotherapy with bleomycin, vincristine, and methotrexate plus split-course radiotherapy in the treatment of non-oat-cell bronchogenic carcinoma. Cancer Chemother Rep 59:377, 1975
   PubMedGoogle Scholar
• Lanzotti VJ, Ward DN, Samuels M: Bleomycin followed by cyclophosphamide, vincristine, methotrexate and 5-fluorouracil for non-oat-cell bronchogenic carcinoma. Proc AACR 16:112, 1975
   Google Scholar
• Livingston RB, Einhorn LH, Burgess MA: Advances in treatment of recurrent and disseminated squamous carcinoma of the lung, head and neck. In Cancer Chemotherapy,5 pp 233–251
   Google Scholar
• Samuels ML, Holoye PY, Johnson DE: Bleomycin, combination chemotherapy programs in testicular cancer. In Cancer Chemotherapy,5 pp 483–493
   Google Scholar